Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in central China

Archives of Virology

Volumn 158, Issue 9, 2013, Pages 1889-1894

  Chen, Xi ^a   He, Jian Mei ^a   Ding, Li Sha ^a   Zhang, Guo Qiang ^a   Zou, Xiao Bai ^a   Zheng, Jun ^a  

^a Hunan Provincial Center for Disease Control and Prevention   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; ARTICLE; BLOOD; CHINA; CLASSIFICATION; FEMALE; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MALE; MIDDLE AGED; MIXED INFECTION; PREVALENCE; RISK FACTOR; SUBSTANCE ABUSE; VIROLOGY;

ADULT; CHINA; COINFECTION; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84883271996     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-013-1681-z     Document Type: Article

References (37)

1. Thio CL (2003) Hepatitis B in the human immunodeficiency virus-infected patients: epidemiology, natural history, and treatment. Semin Liver Dis 23: 125-136.
2. Taylor LE, Swan T, Mayer KH (2012) HIV coinfection with hepatitis C virus: evolving epidemiology and treatment paradigms. Clin Infect Dis 55(suppl 1): S33-S42.
3. Alter M (2006) Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 44: S6-S9.
4. Adewole OO, Anteyi E, Ajuwon Z, Wada I, Elegba F, Ahmed P, Betiku Y, Okpe A, Eze S, Ogbeche T, Erhabor GE (2009) Hepatitis B and C virus co-infection in Nigerian patients with HIV infection. J Infect Dev Ctries 3: 369-375.
5. Hoffman C, Thio C (2007) Clinial implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis 7: 402-409.
6. Soriano V, Barreiro P, Nunez M (2006) Management of chronic hepatitis B and C in HIV-coinfected patients. J Antimicrob Chemother 57: 815-818.
7. Lacombe K, Bottero J, Lemoine M, Boyd A, Girard PM (2010) HIV/hepatitis B virus co-infection: current challenges and new strategies. J Antimicrob Chemother 65: 10-17.
8. Chun HM, Roediger MP, Hullsiek KH, Thio CL, Agan BK, Bradley WP, Peel SA, Jagodzinski LL, Weintrob AC, Ganesan A, Wortmann G, Crum-Cianflone NF, Maguire JD, Landrum ML (2012) Infectious Disease Clinical Research Program HIV Working Group: Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters. Clin Infect Dis 205: 185-193.
9. Nikolopoulos GK, Paraskevis D, Hatzitheodorou E, Moschidis Z, Sypsa V, Zavitsanos X, Kalapothaki V, Hatzakis A (2009) Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis. Clin Infect Dis 48: 1763-1771.
10. Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, Miyakawa Y, Mayumi M (1988) Typing hepatitis B virus by homology in nucleotide sequences: comparison of surface antigen subtypes. J Gen Virol 69: 2575-2583.
11. Norder H, Courouse AM, Magnius LO (1994) Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 198: 489-503.
12. Stuyver L, De Gendt S, van Geyt C, Zoulim F, Fried M, Schinazi RF, Rossau R (2000) A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol 81: 67-74.
13. Arauz-ruiz P, Norder H, Robertson BH, Magnius LO (2002) Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol 83: 2059-2073.
14. Olinger CM, Jutavijittum P, Hubschen JM, Yousukh A, Samountry B, Thammavong T, Toriyama K, Muller CP (2008) Possible new hepatitis B virus genotype, southeast Asia. Emerg Infect Dis 14: 1777-1780.
15. Tatematsu K, Tanaka Y, Kurbanov F, Sugauchi F, Mano S, Maeshiro T, Nakayoshi T, Wakuka M, Miyakawa Y, Mizokami M (2009) A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol 83: 10538-10547.
16. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LQ (2004) Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47: 289-309.
17. Pourkarim MR, Lemey P, Amini-Bavil-Olyaee S, Houspie L, Verbeeck J, Rahman M, Maes P, Vanwijingaerden E, Nevens F, van Ranst M (2011) Molecular characterization of hepatitis B virus strains circulating in Belgian patients co-infected with HIV and HBV: overt and occult infection. J Med Virol 83: 1876-1884.
18. Shibayama T, Masuda G, Ajisawa A, Hiruma K, Tsuda F, Nishizawa T, Takahashi M, Okamoto H (2005) Characterization of seven genotypes (A to E, G and H) of hepatitis B virus recovered from Japanese patients infected with human immunodeficiency virus type 1. J Med Virol 76: 24-32.
19. Fujisaki S, Ykomaku Y, Shiino T, Koibuchhi T, Hattori J, Ibe S, Iwatani Y, Iwamoto A, Shirasaka T, Hamaguchi M, Sugiura W (2011) Outbreak of infections by hepatitis B virus genotype A and transmission of genetic drug resistance in patients coinfected with HIV-1 in Japan. J Clin Microbiol 49: 1017-1024.
20. Ramos B, Nunez M, Martin-Carbonero L, Sheldon J, Rios P, Labarga P, Romero M, Barreiro P, Garcia-Samaniego J, Soriano V (2007) Hepatitis B virus genotypes and lamivudine resistance mutations in HIV/hepatitis B virus-coinfected patients. J Acquir Immune Defic Syndr 44: 557-561.
21. Quarleri J, Moretti F, Bouzas MB, Laufer N, Carrillo MG (2007) giuliano SF, Perez H, Cahn P, Salomo H. Hepatitis B virus genotype distribution and its lamivudine-resistant mutants in HIV-coinfected patients with chronic occult hepatitis B. AIDS Res Hum Retroviruses 23: 525-531.
22. Damerow H, Yuen L, Wiegand J, Walker C, Bock CT, Locarnini S, Tillmann HL (2010) Mutation pattern of lamivudine resistance in relation to hepatitis B genotypes: hepatitis B genotypes differ in their lamivudine resistance associated mutation pattern. J Med Virol 82: 1850-1858.
23. Sheng WH, Hung CC, Chang SY, Liu CJ, Chen MY, Hsieh SM, Kao JH, Chen PJ, Chang SC (2012) Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highy active antiretroviral therapy. Clin Infec Dis 54: 548-555.
24. Lada O, Gervais A, Branger M, Peytavin G, Roquebert B, Collin G, Fraqueiro G, Moucari R, Hamet G, Martinot-Peignoux M, Matheron S, Marcellin P (2012) Long-term outcome of primary non-responders to tenofovir therapy in HIV/HBV-co-infected patients: impact of HBV genotype G. Liver Int 32: 93-101.
25. Dao DY, Balko J, Attar N, Neak E, Yuan HJ, Lee WM, Jain MK (2011) Hepatitis B virus genotype G: prevalence and impact in patients co-infected with human immunodeficiency virus. J Med Virol 83: 1551-1558.
26. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, Wang F, Zheng H, Wang F, Guo J, Ma J, Wang H, Luo H, Li L, Jin S, Hadler SC, Wang Y (2009) Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 27: 6550-6557.
27. Zeng G, Wang Z, Wen S, Jiang J, Wang L, Cheng J, Tan D, Xiao F, Ma S, Li W, Luo K, Naoumov NV, Hou J (2005) Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China. J Viral Hepatitis 12: 609-617.
28. Wu Z, Sullivan SG, Wang Y, Rotheram-Borus MJ, Detels R (2007) Evolution of China's response to HIV/AIDS. Lancet 369: 679-690.
29. He N, Chen L, Lin HJ, Zhang M, Wei J, Yang JH, Gabrio J, Rui BL, Zhang ZF, Fu ZH, Ding YY, Zhao GM, Jiang QW, Detels R (2011) Multiple viral coinfections among HIV/AIDS patients in China. Biosci Trends 5: 1-9.
30. Shen Y, Wang Z, Qi T, Jiang X, Song W, Tang J, Liu L, Zhang R, Zheng Y, Dai Z, Lu H (2013) Serological survey of viral hepatitis markers among newly diagnosed patients with HIV/AIDS in China. HIV Med 14: 167-175.
31. Spradling PR, Richardson JT, Buchacz K, Moorman AC, Brooks JT (2010) HIV Outpatient Study (HOPS) Investigators: prevalence of chronic hepatitis B virus infection among patients in the HIV outpatients study, 1996-2007. J Viral Hepat 17: 879-886.
32. Yang R, Gui X, Xiong Y, Gao S, Zhang Y, Deng L, Liang K, Yan Y, Rong Y (2011) Risk of liver-associated morbidity and mortality in a cohort of HIV and HBV coinfected Han Chinese. Infection 39: 427-431.
33. Winnock M, Bani-Sadr F, Pambrun E, Loko MA, Lascoux-Combe C, Garipuy D, Rosenthal E, Carrieri P, Dabis F, Salmon D (2011) Prevalence of immunity to hepatitis viruses A and B in a large cohort of HIV/HCV-coinfected patients, and factors associated with HAV and HBV vaccination. Vaccine 29: 8656-8660.
34. Gandhi RT, Wurcel A, Lee H, McGovern B, Boczanowski M, Gerwin R, Corcoran CP, Szczepiorkowski Z, Toner S, Cohen DE, Sax PE, Ukomadu C (2003) Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals. Clin Infect Dis 36: 1602-1605.
35. French AL, Operskalski E, Peters M, Strickler HD, Tien PC, Sharp GB, Glesby MJ, Young M, Augenbraun M, Seaberg E, Kovacs A (2007) Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women. J Infect Dis 195: 1437-1442.
36. Garten RJ, Zhang J, Lai S, Liu W, Chen J, Yu XF (2005) Coinfection with HIV and hepatitis C virus among injection drug users in southern China. Clin Infect Dis 41(Suppl 1): S18-S24.
37. Liu JY, Lin HH, Liu YC, Lee SS, Chen YL, Hung CC, Ko WC, Huang CK, Lai CH, Chen YS, Shih YL, Chung HC, Liang SH, Lin JN (2008) Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan. Clin Infect Dis 46: 1761-1768.